Veterinary Pharmacology
| Topics 1-10: | Basic Principles of Pharmacology |
| Topics 11-16: | Drugs Affecting the Nervous System |
| Topics 17-20: | Autacoids and Anti-Inflammatory Agents |
| Topics 21-30: | Antiinfectives |
| Topics 31-37: | Drugs Affecting Organ System (Gastrointestinal System, Cardiovascular System) |
| Topics 38-40: | Topicals, Drugs Interactions |
Estimate of Contact Hours |
||
|---|---|---|
| Topic 1 | INTRODUCTION TO PHARMACOLOGY |
|
A. |
Definitions | 0.25 |
B. |
Introduction to considerations for appropriate use of drugs | 0.25 |
|
||
C. |
Drug laws and regulations | 0.50 |
|
||
| Topics 2-3 | MOLECULAR MECHANISMS OF DRUG ACTION |
|
A. |
Receptors and drug-receptor interactions | 0.50 |
|
||
B. |
Quantitative aspects of drug-receptor interactions (the dose-response curve) | 1.00 |
|
||
C. |
Drug safety | 0.25 |
|
||
D. |
Factors affecting membrane transport of drugs | 0.25 |
|
||
| Topics 4-5 | DRUG BIOTRANSFORMATION |
|
A. |
Chemical pathways and substrates affected | 1.5 |
|
||
B. |
Enzymatic systems for drug metabolism | 0.25 |
|
||
C. |
Factors influencing drug metabolism | 0.25 |
|
||
| Topics 6-10 | BASIC PHARMACOKINETICS |
|
A. |
Drug absorption and role of the route of administration | 1.00 |
|
||
B. |
Drug distribution | 0.50 |
|
||
C. |
Drug clearance | 1.00 |
|
||
D. |
Pharmacokinetics for rational dosage adjustment | 2.00 |
|
||
E. |
Bioequivalence and bioavailability | 0.25 |
F. |
Constructing pharmacokinetic models | 0.25 |
Estimate of Contact Hours |
||
|---|---|---|
| Topics 11-15 | DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM |
|
A. |
Considerations for therapeutic use of drugs affecting the Autonomic Nervous System | 0.50 |
B. |
Sympathomimetics (Adrenergic Agonists) | 1.50 |
|
||
C. |
Sympatholytics (Adrenergic Antagonists) | 1.00 |
|
||
D. |
Cholinergic agonists | 1.25 |
|
||
E. |
Antimuscarinic drugs | 0.25 |
F. |
Drugs acting at nicotinic receptors | 0.25 |
|
||
G. |
CNS and ANS integration | 0.25 |
|
||
| Topic 16 | PHARMACOLOGY OF THE CENTRAL NERVOUS SYSTEM |
1.00 |
A. |
CNS transmitters and receptors, drug action, and therapeutic implications | |
|
||
B. |
Classes of drugs involved | |
|
Estimate of Contact Hours |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Topics 17-20 | AUTACOIDS AND ANTI INFLAMMATORY AGENTS |
|||||||||||||
A. |
General principles of autacoid therapeutics |
1.00 |
||||||||||||
|
||||||||||||||
B. |
Glucocorticoids, mineralocorticoids, and antagonists | 1.00 |
||||||||||||
|
||||||||||||||
C. |
Reproductive hormones | |||||||||||||
D. |
Non steroidal anti inflammatory agents | 0.75 |
||||||||||||
|
||||||||||||||
E. |
Other anti inflammatory/analgesic drugs | 0.75 |
||||||||||||
|
||||||||||||||
F. |
Antihistamines | 0.50 |
||||||||||||
|
Estimate of Contact Hours |
||
|---|---|---|
| Topics 21-22 | INTRODUCTION TO ANTIINFECTIVES AND SYSTEMIC ANTIMICROBIAL AGENTS |
|
A. |
Definitions; factors contributing to treatment success | 0.50 |
B. |
Sulfonamides | 0.75 |
|
||
C. |
Fluoroquinolones | 0.50 |
|
||
D. |
Other antimicrobials | 0.25 |
|
||
| Topics 23-28 | ANTIBIOTICS AND ANTIFUNGALS |
|
A. |
Penicillins | 1.75 |
|
||
B. |
Cephalosporins | 0.75 |
|
||
C. |
Polypeptide and glycopeptide antibiotics | 0.25 |
|
||
D. |
Aminoglycosides | 0.75 |
|
||
E. |
Tetracyclines | 0.75 |
|
||
F. |
Chloramphenicol & relatives | 0.50 |
|
||
G. |
Macrolides, lincosamides and ionophores | 0.50 |
|
||
H. |
Antifungal agents | 0.75 |
|
||
| Topics 29,30 | ANTIVIRAL AGENTS AND ANTINEOPLASTICS |
|
A. |
Antiviral agents | 0.50 |
|
||
B. |
Antineoplastics | 1.50 |
|
Estimate of Contact Hours |
||
|---|---|---|
| Topics 31,32 | AGENTS ACTING ON THE GASTROINTESTINAL TRACT |
|
A. |
Ruminant considerations in drug therapy | 0.25 |
B. |
Induction and control of emesis | 0.50 |
C. |
Decreasing effects of gastric acid | 0.50 |
|
||
D. |
Agents affecting gastrointestinal motility | 0.75 |
|
||
| Topics 33- 37 | CARDIOVASCULAR DRUGS |
|
A. |
Anticoagulants, coagulants, hematinics | 0.50 |
|
||
B. |
Fluids and diuretics | 0.50 |
|
||
C. |
Vasodilators and antihypertensives |
1.25 |
|
||
D. |
Cardiotonics | 0.75 |
|
||
E. |
Antiarrhythmia agents | 2.00 |
|
Estimate of Contact Hours |
||
|---|---|---|
| Topic 38 | TOPICAL AGENTS |
1.00 |
A. |
Agents used on skin | |
|
||
B. |
Local anesthetics | |
C. |
Agents applied topically | |
|
||
D. |
Antitussive, expectorant, and mucolytic agents | |
| Topics 39-40 | DRUG INTERACTIONS |
|
A. |
Mechanism of interactions | 1.00 |
|
||
B. |
Interactions by drug classes | 0.75 |
|
||
C. |
Therapies in which drug interactions should be considered | 0.25 |
Lecture total |
40 |
|
| Midterm Exam | 2 |
|
TOTAL |
42 |
|
|
||